Skip to main content
Premium Trial:

Request an Annual Quote

Genospectra, French CNRS to Co-Develop Delivery Reagents; Firm Exclusively Licenses Tech

NEW YORK, July 19 (GenomeWeb News) - Genospectra has licensed a technology to deliver reagents into cells from the French National Center for Scientific Research and will collaborate with CNRS to develop new delivery reagents, the company said today.


The agreement gives Fremont-Calif.-based Genospectra an exclusive worldwide license to the MPG technology, which was developed by researchers at the CNRS in Montpellier. The partners plan to co-develop a panel of delivery reagents optimized to transfer a wide variety of molecules into live cells, which Genospectra has the right to market and sell.


Genospectra and CNRS have been collaborating for two years, and Genospectra recently released its first delivery reagent based on the technology for transferring siRNA into cells.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.